KORU Medical Systems, Inc.
HealthcareNASDAQ:KRMD · NASDAQ Capital Market
+$0.00 today
Vol 0.09M · Avg 0.14M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$43.3M of revenue converted into -$2.3M of net income for the selected period. Gross margin is 61.5% and net margin is -5.2%, showing how much revenue survives after costs and taxes. EPS is $-0.05, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.1M +22.2% | $33.6M +18.0% | $28.5M +2.2% | $27.9M +18.8% | $23.5M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $15.5M +26.1% | $12.3M +4.3% | $11.8M -5.7% | $12.5M +28.9% | $9.7M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $25.6M +20.0% | $21.3M +27.7% | $16.7M +8.7% | $15.4M +11.6% | $13.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 62.3% -1.1pp | 63.4% +4.8pp | 58.6% +3.5pp | 55.1% -3.5pp | 58.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $4.4M -16.6% | $5.3M -8.4% | $5.7M +15.9% | $5.0M +100.4% | $2.5M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $23.4M | $0 | $0 | $0 | $0 | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $28.6M +2.9% | $27.8M +3.0% | $27.0M +3.2% | $26.1M +25.7% | $20.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $810.5K +4.9% | $772.9K -11.2% | $870.4K +48.2% | $587.1K +26.8% | $463.1K | $374.2M | $1.2B | $631.8M |
| EBITDA | -$1.8M +65.9% | -$5.3M +40.6% | -$8.9M +11.7% | -$10.1M -70.9% | -$5.9M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -4.4% +11.3pp | -15.7% +15.5pp | -31.2% +4.9pp | -36.2% -11.0pp | -25.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$3.0M +53.9% | -$6.4M +37.2% | -$10.3M +4.7% | -$10.8M -53.4% | -$7.0M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -7.2% +11.9pp | -19.2% +16.9pp | -36.0% +2.6pp | -38.6% -8.7pp | -29.9% | 16.6% | 24.1% | 22.0% |
| Interest Income | $293.4K -34.0% | $444.6K -20.8% | $561.3K +285.6% | $145.6K +1012.8% | $13.1K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $356.4K -6.8% | $382.5K -22.9% | $496.4K +369.6% | $105.7K -84.1% | $665.1K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$2.6M +56.9% | -$6.1M +38.0% | -$9.8M +8.4% | -$10.7M -67.7% | -$6.4M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -6.4% +11.7pp | -18.0% +16.3pp | -34.3% +4.0pp | -38.3% -11.2pp | -27.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $21.9K +656.7% | $2.9K -99.9% | $4.0M +297.0% | -$2.0M -11.8% | -$1.8M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$2.6M +56.5% | -$6.1M +55.9% | -$13.7M -58.7% | -$8.7M -89.8% | -$4.6M | $4.9B | $4.8B | $4.7B |
| Net Margin | -6.4% +11.6pp | -18.0% +30.2pp | -48.2% -17.1pp | -31.0% -11.6pp | -19.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$0 +56.1% | -$0 +56.7% | -$0 -57.9% | -$0 -90.0% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$0 +56.1% | -$0 +56.7% | -$0 -57.9% | -$0 -90.0% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $46.2M +0.8% | $45.8M +0.4% | $45.6M +1.3% | $45.0M +1.4% | $44.4M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $46.2M +0.8% | $45.8M +0.4% | $45.6M +1.3% | $45.0M +1.4% | $44.4M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Prenetics Global Limited
NASDAQ:PRE
$367.72M
OraSure Technologies, Inc.
NASDAQ:OSUR
$287.79M
Utah Medical Products, Inc.
NASDAQ:UTMD
$216.00M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
InfuSystem Holdings, Inc.
AMEX:INFU
$184.46M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
MaxCyte, Inc.
NASDAQ:MXCT
$119.98M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Nyxoah S.A.
NASDAQ:NYXH
$55.05M
Vyome Holdings, Inc.
HIND
$12.95M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does KRMD generate?
KORU Medical Systems, Inc. (KRMD) reported $41.13M of revenue in fiscal 2025.
Is KRMD profitable?
KORU Medical Systems, Inc. (KRMD) reported -$2,637,926.00 of net income, with a net margin of -6.4%.
Explore More
Continue the stock analysis
Jump to another research area for this company.